Immediate Impact
65 standout
Citing Papers
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer (TOPAZ-1): patient-reported outcomes from a randomised, double-blind, placebo-controlled, phase 3 trial
2024 Standout
Oesophageal cancer
2024 Standout
Works of Lukas Werner Widmer being referenced
Docetaxel, Cisplatin, and Fluorouracil; Docetaxel and Cisplatin; and Epirubicin, Cisplatin, and Fluorouracil As Systemic Treatment for Advanced Gastric Carcinoma: A Randomized Phase II Trial of the Swiss Group for Clinical Cancer Research
2007
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Lukas Werner Widmer | 187 | 5 | 172 | 205 | 12 | 320 | |
| Jameson L. Chassin | 254 | 7 | 145 | 145 | 18 | 338 | |
| Duncan Ramsay | 257 | 26 | 96 | 94 | 17 | 330 | |
| K Shute | 190 | 13 | 93 | 170 | 12 | 366 | |
| J. T. Plukker | 174 | 1 | 71 | 211 | 13 | 349 | |
| Jerry Evans | 287 | 5 | 74 | 180 | 10 | 361 | |
| Juliane Bingener-Casey | 209 | 30 | 92 | 176 | 10 | 321 | |
| Rosebel Monteiro | 174 | 14 | 82 | 60 | 14 | 285 | |
| Georgios Peros | 123 | 119 | 86 | 69 | 20 | 312 | |
| Gail Phillips | 165 | 9 | 48 | 86 | 18 | 275 | |
| Sabina Cenciarelli | 183 | 2 | 163 | 115 | 7 | 310 |
All Works
Login with ORCID to disown or claim papers
Loading papers...